During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
At the J.P. Morgan Health Care conference this week in San Francisco, drugmakers had their sights set on the next generation of GLP-1 medications, alternatives, and a growing list of indications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback